Status:
RECRUITING
Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum.
Lead Sponsor:
Hospital Clinic of Barcelona
Conditions:
Dyspareunia
Eligibility:
FEMALE
Phase:
NA
Brief Summary
This study evaluates if the application of resistive capacitive monopolar radiofrequency therapy associated with Thiele massage is effective when treating de novo dyspareunia at 4 to 9 months postpart...
Detailed Description
Dyspareunia is a type of genito-pelvic pain (GPP) that takes place during vaginal penetration at some point in sexual intercourse. It greatly affects quality of life as well as psychological and sexua...
Eligibility Criteria
Inclusion
- 4-9 postpartum
- de novo dyspareunia after delivery
- obstetric injury
- Grant informed consent
Exclusion
- radiofrequency contraindications (pacemaker, active infection or pregnancy)
- cesarean section
- dyspareunia previous to labour
- previous vulvo-vaginal pathology
- patients with postpartum depression
- patients with a pelvic region oncological history
Key Trial Info
Start Date :
March 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05417334
Start Date
March 18 2021
End Date
January 1 2026
Last Update
December 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinic Barcelona
Barcelona, Spain, 08036